Cloning and Expression of N22 Region of Torque Teno Virus (TTV) Genome and Use of Peptide in Developing Immunoassay for TTV Antibodies

Overview

Journal Virol J

Publisher Biomed Central

Specialty Microbiology

Date 2014 Jun 3

PMID 24884576

Citations 7

Authors

Dhananjay Singh Mankotia

Mohammad Irshad

Affiliations

Soon will be listed here.

Abstract

Background: Torque Teno Virus (TTV) is a DNA virus with high rate of prevalence globally. Since its discovery in 1997, several studies have questioned the role of this virus in causing disease. However, it still remains an enigma. Although methods are available for detection of TTV infection, there is still a need for simple, rapid and reliable method for screening of this virus in human population. Present investigation describes the cloning and expression of N22 region of TTV-genome and the use of expressed peptide in development of immunoassay to detect anti-TTV antibodies in serum. Since TTV genotype-1 is more common in India, the serum positive for genotype-1 was used as source of N22 for expression purpose.

Methods: Full length N22 region of ORF1 from TTV genotype-1 was amplified and cloned in pGEM®-T Easy vector. After cloning, the amplicon was transformed and expressed as a fusion protein containing hexa-histidine tag in pET-28a(+) vector using BL21 E. coli cells as host. Expression was conducted both in LB medium as well as ZYP-5052 auto-induction medium. The expressed peptide was purified using metal-chelate affinity chromatography and used as antigen in developing a blot immunoassay.

Results: Analysis of translated product by SDS-PAGE and western blotting demonstrated the presence of 25 kDa polypeptide produced after expression. Solubility studies showed the polypeptide to be associated with insoluble fraction. The use of this peptide as antigen in blot assay produced prominent spot on membrane treated with sera from TTV-infected patients. Analysis of sera from 75 patients with liver and renal diseases demonstrated a successful implication of N22 polypeptide based immunoassay in screening sera for anti-TTV antibodies. Comparison of the immunoassay developed using expressed N22 peptide with established PCR method for TTV-DNA detection showed good coherence between TTV-DNA and presence of anti-TTV antibodies in the sera analysed.

Conclusions: This concludes that TTV N22 region may be expressed and safely used as antigen for blot assay to detect anti-TTV antibodies in sera.

Citing Articles

Genetic Analysis of Torque Teno Canis Virus Identified in Republic of Korea.

Kim D, Ahn H, Han S, Go H, Kim D, Kim J Vet Sci. 2022; 9(12).

PMID: 36548854 PMC: 9782174. DOI: 10.3390/vetsci9120693.

Virome in the Lungs: The Role of Anelloviruses in Childhood Respiratory Diseases.

Dodi G, Attanasi M, Di Filippo P, Di Pillo S, Chiarelli F Microorganisms. 2021; 9(7).

PMID: 34201449 PMC: 8307813. DOI: 10.3390/microorganisms9071357.

Torque teno virus in liver diseases: On the way towards unity of view.

Reshetnyak V, Maev I, Burmistrov A, Chekmazov I, Karlovich T World J Gastroenterol. 2020; 26(15):1691-1707.

PMID: 32351287 PMC: 7183866. DOI: 10.3748/wjg.v26.i15.1691.

Human anelloviruses: diverse, omnipresent and commensal members of the virome.

Kaczorowska J, van der Hoek L FEMS Microbiol Rev. 2020; 44(3):305-313.

PMID: 32188999 PMC: 7326371. DOI: 10.1093/femsre/fuaa007.

Torquetenovirus Serum Load and Long-Term Outcomes in Renal Transplant Recipients.

Gore E, Gomes-Neto A, Wang L, Bakker S, Niesters H, de Joode A J Clin Med. 2020; 9(2).

PMID: 32041187 PMC: 7073853. DOI: 10.3390/jcm9020440.

References

Devalle S, Niel C . Distribution of TT virus genomic groups 1-5 in Brazilian blood donors, HBV carriers, and HIV-1-infected patients. J Med Virol. 2003; 72(1):166-73. DOI: 10.1002/jmv.10564. View

Lo S, Peng K, Ma H, Yu J, Li Y, Lin H . Prevalence of TT virus DNA in eastern Taiwan aborigines. J Med Virol. 1999; 59(2):198-203. DOI: 10.1002/(sici)1096-9071(199910)59:2<198::aid-jmv12>3.0.co;2-2. View

MUSHAHWAR I, Erker J, Muerhoff A, Leary T, Simons J, Birkenmeyer L . Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. Proc Natl Acad Sci U S A. 1999; 96(6):3177-82. PMC: 15915. DOI: 10.1073/pnas.96.6.3177. View

Peng Y, Nishizawa T, Takahashi M, Ishikawa T, Yoshikawa A, Okamoto H . Analysis of the entire genomes of thirteen TT virus variants classifiable into the fourth and fifth genetic groups, isolated from viremic infants. Arch Virol. 2002; 147(1):21-41. DOI: 10.1007/s705-002-8301-7. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Irshad M, Sharma Y, Dhar I, Singh J, Joshi Y . Transfusion-transmitted virus in association with hepatitis A-E viral infections in various forms of liver diseases in India. World J Gastroenterol. 2006; 12(15):2432-6. PMC: 4088084. DOI: 10.3748/wjg.v12.i15.2432. View

Feher E, Gall T, Murvai M, Kis A, Boda R, Sapy T . Investigation of the occurrence of torque tenovirus in malignant and potentially malignant disorders associated with human papillomavirus. J Med Virol. 2009; 81(11):1975-81. DOI: 10.1002/jmv.21627. View

Szladek G, Juhasz A, Kardos G, Szoke K, Major T, Sziklai I . High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma. J Clin Pathol. 2005; 58(4):402-5. PMC: 1770630. DOI: 10.1136/jcp.2004.022103. View

Irshad M, Singh S, Irshad K, Agarwal S, Joshi Y . Torque teno virus: its prevalence and isotypes in North India. World J Gastroenterol. 2008; 14(39):6044-51. PMC: 2760200. DOI: 10.3748/wjg.14.6044. View

10.

Handa A, Dickstein B, Young N, Brown K . Prevalence of the newly described human circovirus, TTV, in United States blood donors. Transfusion. 2000; 40(2):245-51. DOI: 10.1046/j.1537-2995.2000.40020245.x. View

11.

Takayama S, Yamazaki S, Matsuo S, Sugii S . Multiple infection of TT virus (TTV) with different genotypes in Japanese hemophiliacs. Biochem Biophys Res Commun. 1999; 256(1):208-11. DOI: 10.1006/bbrc.1999.0270. View

12.

Irshad M, Joshi Y, Sharma Y, Dhar I . Transfusion transmitted virus: A review on its molecular characteristics and role in medicine. World J Gastroenterol. 2006; 12(32):5122-34. PMC: 4088008. DOI: 10.3748/wjg.v12.i32.5122. View

13.

Miyata H, Tsunoda H, Kazi A, Yamada A, Khan M, Murakami J . Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus. J Virol. 1999; 73(5):3582-6. PMC: 104131. DOI: 10.1128/JVI.73.5.3582-3586.1999. View

14.

de Villiers E, Bulajic M, Nitsch C, Kecmanovic D, Pavlov M, Kopp-Schneider A . TTV infection in colorectal cancer tissues and normal mucosa. Int J Cancer. 2007; 121(9):2109-2112. DOI: 10.1002/ijc.22931. View

15.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

16.

Tsuda , Takahashi , Nishizawa , Akahane , Konishi , Yoshizawa . IgM-class antibodies to TT virus (TTV) in patients with acute TTV infection. Hepatol Res. 2001; 19(1):1-11. DOI: 10.1016/s1386-6346(00)00086-3. View

17.

Irshad M, Mandal K, Singh S, Agarwal S . Torque teno virus infection in hemodialysis patients in North India. Int Urol Nephrol. 2009; 42(4):1077-83. DOI: 10.1007/s11255-009-9648-4. View

18.

Kakkola L, Hedman K, Vanrobaeys H, Hedman L, Soderlund-Venermo M . Cloning and sequencing of TT virus genotype 6 and expression of antigenic open reading frame 2 proteins. J Gen Virol. 2002; 83(Pt 5):979-990. DOI: 10.1099/0022-1317-83-5-979. View

19.

Tomasiewicz K, Modrzewska R, Lyczak A, Krawczuk G . TT virus infection and pancreatic cancer: relationship or accidental coexistence. World J Gastroenterol. 2005; 11(18):2847-9. PMC: 4305932. DOI: 10.3748/wjg.v11.i18.2847. View

20.

Okamoto H, Takahashi M, Nishizawa T, Ukita M, Fukuda M, Tsuda F . Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology. 1999; 259(2):428-36. DOI: 10.1006/viro.1999.9770. View